The gene encoding the beta(2)-adrenergic receptor (beta(2)AR) is highly pol
ymorphic in the human population. Common polymorphisms in the receptor codi
ng block (amino acids 16 and 27) affect agonist-promoted downregulation. An
other common polymorphism in the 5' leader cistron of the beta(2)AR gene al
so regulates receptor expression, but does so through a mechanism that is i
ndependent of agonist exposure. None of these polymorphisms appears to be c
ausative factor for asthma. However, data from several studies now indicate
that the asthmatic phenotype and therapeutic response may be modified by t
he different polymorphic variants. This modifying effect is not likely due
to a single dominant polymorphic locus, but rather the result of interactio
n among multiple polymorphic loci that regulate receptor expression through
different mechanisms.